104 related articles for article (PubMed ID: 10374712)
1. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
Jolkkonen J; Puurunen K; Koistinaho J; Kauppinen R; Haapalinna A; Nieminen L; Sivenius J
Eur J Pharmacol; 1999 May; 372(1):31-6. PubMed ID: 10374712
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
Umemura K; Shimakura A; Nakashima M
Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
[TBL] [Abstract][Full Text] [Related]
3. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.
Minger SL; Geddes JW; Holtz ML; Craddock SD; Whiteheart SW; Siman RG; Pettigrew LC
Brain Res; 1998 Nov; 810(1-2):181-99. PubMed ID: 9813316
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia.
Kuhmonen J; Pokorný J; Miettinen R; Haapalinna A; Jolkkonen J; Riekkinen P; Sivenius J
Anesthesiology; 1997 Aug; 87(2):371-7. PubMed ID: 9286902
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
Lo EH; Pierce AR; Mandeville JB; Rosen BR
Stroke; 1997 Feb; 28(2):439-46; discussion 446-7. PubMed ID: 9040703
[TBL] [Abstract][Full Text] [Related]
6. The alpha 2 adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations.
Matsumoto M; Zornow MH; Rabin BC; Maze M
Brain Res; 1993 Nov; 627(2):325-9. PubMed ID: 7905353
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
Kuhmonen J; Haapalinna A; Sivenius J
J Neural Transm (Vienna); 2001; 108(3):261-71. PubMed ID: 11341477
[TBL] [Abstract][Full Text] [Related]
8. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
Kristensen BW; Noraberg J; Jakobsen B; Gramsbergen JB; Ebert B; Zimmer J
Brain Res; 1999 Sep; 841(1-2):143-59. PubMed ID: 10546997
[TBL] [Abstract][Full Text] [Related]
9. The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat.
Le Peillet E; Arvin B; Moncada C; Meldrum BS
Brain Res; 1992 Jan; 571(1):115-20. PubMed ID: 1351775
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine does not attenuate increases in excitatory amino acids after transient global ischemia in the rabbit.
Kim HK; Zornow MH; Strnat MA; Maze M
J Neurosurg Anesthesiol; 1996 Jul; 8(3):230-6. PubMed ID: 8803836
[TBL] [Abstract][Full Text] [Related]
11. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
Hu P; Diemer NH; Bruhn T; Johansen FF
J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat.
Yang Y; Li Q; Wang CX; Jeerakathil T; Shuaib A
Neuroreport; 2000 Jul; 11(10):2307-11. PubMed ID: 10923691
[TBL] [Abstract][Full Text] [Related]
13. Focal cerebral ischemia in chronic hypertension: no protection by (R)-phenylisopropyladenosine.
Roussel S; Pinard E; Seylaz J
Brain Res; 1991 Apr; 545(1-2):171-4. PubMed ID: 1860043
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
Goyagi T; Toung TJ; Kirsch JR; Traystman RJ; Koehler RC; Hurn PD; Bhardwaj A
Stroke; 2003 Jun; 34(6):1533-8. PubMed ID: 12738895
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter.
Ganjoo P; Farber NE; Hudetz A; Smith JJ; Samso E; Kampine JP; Schmeling WT
Anesthesiology; 1998 Feb; 88(2):429-39. PubMed ID: 9477064
[TBL] [Abstract][Full Text] [Related]
16. Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia.
Pitsikas N; Brambilla A; Besozzi C; Bonali P; Fodritto F; Grippa N; Scandroglio A; Borsini F
Pharmacol Biochem Behav; 2001 Mar; 68(3):443-7. PubMed ID: 11325397
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model.
Gill R; Nordholm L; Lodge D
Brain Res; 1992 May; 580(1-2):35-43. PubMed ID: 1504814
[TBL] [Abstract][Full Text] [Related]
18. Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats.
Engelhard K; Werner C; Kaspar S; Möllenberg O; Blobner M; Bachl M; Kochs E
Anesthesiology; 2002 Feb; 96(2):450-7. PubMed ID: 11818781
[TBL] [Abstract][Full Text] [Related]
19. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
[TBL] [Abstract][Full Text] [Related]
20. Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats.
Chen TY; Goyagi T; Toung TJ; Kirsch JR; Hurn PD; Koehler RC; Bhardwaj A
Stroke; 2004 May; 35(5):1180-5. PubMed ID: 15031456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
